Articles

Ten years on breast cancer drug may be better

June 6, 2016

Delay in diagnosing and treating breast cancer can be deadly. Contact our lawyers for help.

A study released Sunday showed that staying on hormone therapy for 10 years reduces the risk of a recurrence of breast cancer. Typically the drug, letrozole, is given for only five years sometimes after a course of another hormone therapy tamoxifen.  While many women with early-stage breast cancer live for a long time, they continue to “face an indefinite risk of relapse,” said the lead researcher of the new study.  This new research will help further reduce the risk of breast cancer recurrences.

If you suffered a delay in diagnosis of breast cancer at an Army, Navy or Air Force medical facility please contact us for a free consultation. Our malpractice lawyers have over 30 years of experience getting justice for military dependents in all 50 states and it all military healthcare facilities overseas.

DISCLAIMER: An attorney-client relationship with us cannot be formed by transmission or receipt of the information on this Website and any information you send in an e-mail message to this website will not make you a client. We reserve the right to decline any representation for any reason. This Website is for informational purposes only and is not intended to provide legal advice. You should not act or rely on any information in this Website without seeking the advice of a lawyer